Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use

INTRODUCTION: Lisdexamfetamine dimesylate (LDX) is a long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). Post hoc subgroup analyses were performed from two studies in children with ADHD to compare the efficacy of LDX in participants who had received pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jain, Rakesh, Babcock, Thomas, Burtea, Teodor, Dirks, Bryan, Adeyi, Ben, Scheckner, Brian, Lasser, Robert, Renna, John, Duncan, Don
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2013
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3680667/
https://ncbi.nlm.nih.gov/pubmed/23681505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-013-0027-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires